Clinical Trial Update: Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous cord blood mononuclear cells for bronchopulmonary dysplasia in very preterm neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Neonatal Death
• Premature Birth

Drugs mentioned

• Autologous cord blood mononuclear cells

Snippet

Sponsor: Guangdong Women and Children Hospital | Conditions: Bronchopulmonary Dysplasia, Premature | Phase 2 | Status: COMPLETED